Profile cover photo
Profile photo
TriLink BioTechnologies
23 followers -
TriLink manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. TriLink holds the patent on a unique Hot Start PCR solution, CleanAmp™. They operate a quality system based on the FDA’s QSR 21 CFR 820 and the ISO 9001:2008 standard, and practice continual improvement. Since 1996, TriLink's solutions have helped advance drug discovery and biomedical research. Specialties Oligonucleotide Synthesis, Modified Nucleoside Triphosphates, RNA Transcription (Long RNA & mRNA), CleanAmp Hot Start PCR Products, Custom Chemistry
TriLink manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. TriLink holds the patent on a unique Hot Start PCR solution, CleanAmp™. They operate a quality system based on the FDA’s QSR 21 CFR 820 and the ISO 9001:2008 standard, and practice continual improvement. Since 1996, TriLink's solutions have helped advance drug discovery and biomedical research. Specialties Oligonucleotide Synthesis, Modified Nucleoside Triphosphates, RNA Transcription (Long RNA & mRNA), CleanAmp Hot Start PCR Products, Custom Chemistry

23 followers
About
Posts

Post has attachment
Trillions of microbes reside in and on each of us, and influence our health. The compositions of these microbiomes change with our diet, what we drink or breath, and who we come into contact with, whether that be family members, pets, or close friends.

Learn more in today's 'Zone In With Zon' blog post on #Microbiomes.

https://bit.ly/2C70rBS
Photo
Add a comment...

Post has attachment
An #antisense oligonucleotide is the first drug to demonstrate reduction of mutant Huntingtin protein in humans. Learn more in the latest 'Zone In With Zon' blog post today:

https://bit.ly/2EdJk3O
Photo
Add a comment...

Post has attachment
Modified mRNA (Mod-RNA) for therapeutics drives development of new technologies. Learn more in the latest 'Zone In With Zon' blog post on #mRNA.

https://bit.ly/2TQbCXl
Photo
Add a comment...

Post has attachment
Acute Flaccid Myelitis (AFM) is a polio-like disease confirmed in 24 states across the U.S. Recent outbreaks in children are cause for concern. Learn more in the latest 'Zone In With Zon' blog post on #AFM:

https://bit.ly/2Q1tBve
Photo
Add a comment...

Post has attachment
Billionaire Bill Gates bets big on a startup that prints synthetic DNA! Learn more in the latest "Zone In With Zon' blog post on #Biochemistry.

https://bit.ly/2Q7jEZU
Photo
Add a comment...

Post has attachment
Did you attend the 14th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS 2018)? Jerry comments on his OTS 2018 favorites in the latest "Zone In With Zon' blog post. #RNAi #Antisense

View highlights: https://bit.ly/2pVpbal
Photo
Add a comment...

Post has attachment
RNA polymerase ribozymes are in vitro evolved RNA molecules that extend an RNA primer on a complementary RNA template using NTP substrates.
Let's explore more in the latest 'Zone In With Zon' blog post on 3’-End Labeling of RNA or DNA. https://bit.ly/2IwTsVv
Photo
Add a comment...

Post has attachment
Over 400 attendees from around the world congregated at the 2018 International Roundtable (IRT) on #Nucleosides, #Nucleotides and #NucleicAcids at UCSD. View the highlights in the latest 'Zone In With Zon' blog post:

https://bit.ly/2NTuhl2
Photo
Add a comment...

Post has attachment
Strong interest in mRNA therapeutics drives increased numbers of delivery publications. Let's explore more in the latest 'Zone In With Zon' blog post on #mRNA.

https://bit.ly/2MNW9Yj
Photo
Add a comment...

Post has attachment
Jerry spotlights 20 citing oligos, nucleotides, mRNA and aptamers in the latest 'Zone In With Zon' blog post. 10 of the 20 spotlighted items show global reach of TriLink products. Learn more today!

https://goo.gl/kBb2R7
Photo
Add a comment...
Wait while more posts are being loaded